On November 20th, Amanda Harper
passed her candidacy exam for graduate school. Go Amanda!
A manuscript from the Carson Lab entitled, “A Phase I trial of Bortezomib and Interferon Alpha-2B in Metastatic Melanoma” was accepted for publication by the Journal of Immunotherapy
IBGP first year graduate student Christina Knippler
rotated in the Carson Lab. Christina worked with Elizabeth McMichael on projects involving the folate receptor, including in vitro and in vivo studies.
An implementation meeting for the new clinical trial “A pilot study of beta-blockers in patients with advanced cancer” was held this month.
, who previously worked in Dr. Glaser’s lab, was hired by the Carson Lab! Megan will be managing the clinical trial “A pilot study of beta-blockers in patients with advanced cancer” for the Carson Lab.
The Carson lab welcomes new undergraduate volunteer Kallan Opheim
and Dr. Glaser
’s clinical trial entitled, “A pilot study of beta-blockers in patients with advanced cancer” was approved by the Institutional Review Board. This study is a collaboration with Dr.Binkley, Dr. Kendra, Dr. Lemeshow, and Dr. Thomas Olencki.
The Carson Lab welcomes Megan Duggan
, who will be working on a vaccine study and doing basic science research. Megan
will manage the Beta-Blockers clinical trial on the lab side.
MD/PhD first year medical student Anisley Valenciaga
rotated in the Carson lab. During her time in the lab, she worked on optimizing the annexin/PI assay for Caron Lab on cells treated with novel pharmaceuticals.
The Carson Lab would like to wish “good luck” to Bonnie Paul
, who is leaving for a position as a clinical research assistant in Cardiovascular Medicine. Bonnie worked in the Carson lab for 3 years as a Research Assistant, helping with our clinical research on immune suppressor cells.
The Carson Lab welcomes Dr. Nicholas Latchana
, the newest surgical resident to take time out for research. Nick
will be continuing Sara
’s work on miRs in melanoma.
Dr. Martin del Campo
’s work with University of Mississippi Medical Center entitled “Metastatic Melanoma: Lactate Dehydrogenase Levels and CT Imaging Findings of Tumor Devascularization Allow Accurate Prediction of Survival in Patients Treated with Bevacizumab” was published in Radiology. Congratulations, Sara!
Dr. Martin del Campo
has finished her stint in the Carson Lab and is returning to work as a third year surgical resident. During her time in the Carson Lab Sara worked on projects involving miRs in melanoma, and a clinical trial involving dose optimization of Cetuximab in head and neck cancer patients. Best wishes, Sara
The Carson Lab would like to welcome Elizabeth McMichael
, a graduate student who will be earning her PhD with us!
Good luck and best wishes to Dr. Cristina Jaime-Ramire
z as she departs the Carson Lab to go on to new opportunities as a postdoctoral fellow with Dr. Kaur in the Department of Neurological Surgery! We will miss you!January – March 2013
IBGP student Elizabeth McMichael
rotated through the Carson lab this winter. During her rotation Liz completed work on the clinical trial “Enhancement of Cetuximab-Induced Antibody-Dependent Cellular Cytotoxicity (ADCC) with Lenalidomide in Advanced Solid Tumors: A Phase I Study” and presented the unified data to the lab.
Carson Lab undergraduate researcher Gregory Kemper
received an honorable mention at the Denman Undergraduate Research Forum for his poster presentation.
was awarded the prestigious DAAD RISE (Deutcher Akadmedischer Austausch Dienst [German Academic Exhange Service] Research Interships in Engineering) Internship. Greg will be conducting research in Germany for the summer of 2013 !!
z successfully defended her thesis, entitled “The NK Cell-mediated Anti-tumor Effects of a Folate-conjugated Immunoglobulin are Enhanced by Cytokines”. Congratulations Dr. Jaime-Ramirez!
Dr. Joseph Markowitz
was awarded the highly prestigious Postdoctoral Pelotonia Fellowship Program. This program “provides two-year research fellowships for up to 12 of the brightest and most promising postdoctoral candidates who want to help cure cancer”.
Accrual to Dr. Carson's
investigator-initiated trial of IL-12 and cetuximab in patients with head and neck cancer is continuing at a very successful rate.